Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009

Clinical Infectious Diseases

Volumn 54, Issue 3, 2012, Pages 381-383

  Tsuchihashi, Yuuki ^a   Sunagawa, Tomimasa ^a   Yahata, Yuichiro ^a   Takahashi, Hideaki ^a   Toyokawa, Takao ^a   Odaira, Fumito ^a   Ohyama, Takaaki ^a   Taniguchi, Kiyosu ^a   Okabe, Nobuhiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; INFLUENZA VACCINATION; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL INFLUENZA;

ADOLESCENT; CHILD; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; ODDS RATIO; PANDEMICS; RISK FACTORS; SEASONS; TIME FACTORS;

EID: 84855869052     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir787     Document Type: Article

References (12)

1. WHO. New influenza A (H1N1) virus infections: global surveillance summary, May 2009. Wkly Epidemiol Rec 2009;84:173-9.
2. WHO. Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009;84:237-44.
3. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
4. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-52.
5. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010;7:e1000258.
6. Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-17.
7. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658-66. (Pubitemid 47444564)
8. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009. E14(31): pii=19288. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19288.
9. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009;339:b3928.
10. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010;51:1370-9.
11. Skowronski DM, Janjua NZ, Hottes TS, De Serres G. Mechanism for seasonal vaccine effect on pandemic H1N1 risk remains uncertain. Clin Infect Dis 2011;52:831-2; author reply 2-3.
12. Tamura M, Webster RG, Ennis FA. Subtype cross-reactive, infectionenhancing antibody responses to influenza A viruses. J Virol 1994;68:3499-504. (Pubitemid 24177373)